Clin2
NCT06789432Possibly a fitRecruiting

Combination vs single cholesterol drug for Bangladeshi patients

Hyperlipidemia (E.G., Hypercholesterolemia)

Treatments studied

Part of Hormones & metabolism clinical trials.

This study tests whether a combination of two cholesterol-lowering medicines (atorvastatin and ezetimibe) works better than a higher dose of one medicine alone in Bangladeshi adults with high cholesterol and low to moderate heart risk.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
500 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have high LDL cholesterol that needs treatment.
  • You have low to moderate heart disease risk (no other major health issues or diabetes less than 10 years).
  • You do not have any serious liver or kidney problems.
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06686615Recruiting
Study of a triple cholesterol medicine combination in high-risk patients

This study tests a cholesterol-lowering combination of three medicines: bempedoic acid, ezetimibe, and a statin (atorvastatin or rosuvastatin). It is for people with high cholesterol, especially those at high risk for heart problems, who need stronger treatment.

Braunau am Inn
NCT07083206Recruiting
Pitavastatin/ezetimibe for high cholesterol

This trial tests a combination pill of two cholesterol-lowering medicines (pitavastatin and ezetimibe) in adults who have been taking either atorvastatin or rosuvastatin for at least 3 months. It aims to see if switching to this new combination is safe and effective.

Yongin-si
NCT06186037Recruiting· Phase 4
Lower-dose combo vs. higher-dose alone for heart artery disease

This trial compares a lower-dose cholesterol pill (rosuvastatin plus ezetimibe) to a higher-dose version of just rosuvastatin for people with mild to moderate heart artery blockages who have not had a stent or bypass. It aims to see which approach works better and is safer.

Suwon, Gyeonggi-do
NCT06767774Recruiting· Phase 4
Comparing two cholesterol treatments for heart patients

This study compares two different ways of lowering cholesterol: a moderate statin (pitavastatin) plus another drug (ezetimibe) versus a stronger statin alone. The goal is to see which approach is safer regarding the risk of developing new diabetes.

Seoul
NCT06784557Recruiting· Phase 4
Study of ezetimibe's effect on gut bacteria

This trial tests whether ezetimibe, a cholesterol-lowering drug, changes the bacteria in your gut. It may help people with heart disease or high cholesterol who are already on a statin.

Seoul
NCT06314919Recruiting
Study of a combination pill for high cholesterol

This study tests a single pill that combines two cholesterol-lowering medicines (pitavastatin and ezetimibe). It may be a good fit if you already take a statin or a statin plus ezetimibe and your doctor wants to adjust your treatment.

Seoul

Hear when a new Hyperlipidemia (E.G., Hypercholesterolemia) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.